Daxor Current Ratio 2010-2011 | DXR

Daxor current ratio from 2010 to 2011. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Daxor Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2011-12-31 $0.08B $0.05B 1.66
2011-09-30 $0.08B $0.05B 1.67
2011-06-30 $0.09B $0.05B 1.83
2011-03-31 $0.09B $0.05B 1.90
2010-12-31 $0.09B $0.04B 1.98
2010-09-30 $0.08B $0.04B 2.18
2010-06-30 $0.08B $0.04B 2.06
2010-03-31 $0.08B $0.04B 2.07
2009-12-31 $0.07B $0.03B 2.61
2009-09-30 $0.08B $0.03B 2.61
2009-06-30 $0.07B $0.03B 2.42
2009-03-31 $0.06B $0.03B 1.97
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.053B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.312B 19.41
Encompass Health (EHC) United States $12.264B 24.50
DaVita (DVA) United States $9.850B 14.09
Elanco Animal Health (ELAN) United States $9.117B 20.39
Chemed (CHE) United States $6.673B 22.35
RadNet (RDNT) United States $5.520B 199.33
Option Care Health (OPCH) United States $4.655B 19.92
LifeStance Health (LFST) United States $2.131B 0.00
Addus HomeCare (ADUS) United States $2.123B 22.85
Astrana Health (ASTH) United States $1.792B 62.67
Aveanna Healthcare Holdings (AVAH) United States $1.671B 30.77
U.S Physical Therapy (USPH) United States $1.260B 31.52
Atai Life Sciences (ATAI) Germany $0.982B 0.00
Pennant (PNTG) United States $0.830B 29.28
MEDIROM Healthcare Technologies (MRM) Japan $0.051B 0.00
Psychemedics (PMD) United States $0.000B 0.00